仙琚制药：关于取得倍他米松磷酸钠注射液境内生产药品注册证书的公告

Group 1 - The core point of the article is that Xianju Pharmaceutical has received approval from the National Medical Products Administration for the injection of Betamethasone Sodium Phosphate, which will enhance its product line [1] - The approved specification for the injection is 1ml: 4mg, classified as a Class 3 chemical drug, intended for diseases requiring glucocorticoid treatment [1] - The product has been deemed to have passed the consistency evaluation, indicating its quality and efficacy are in line with existing standards [1]